Board of Directors
Mr. Dan Pelak
Dan Pelak serves as Chairman of the K2M Board of Directors. Mr. Pelak has over twenty years of experience as a senior executive in the medical technology industry, compiling a successful track record in growing young companies and corporate operating divisions. He was previously the Chief Executive Officer at InnerPulse, a privately held, early-stage cardiac medical device company with a cutting-edge alternative to traditional cardiac rhythm management devices. Before joining InnerPulse, he was the Chief Executive Officer of Closure Medical Corporation, a publically traded global leader in the development and manufacture of biomaterial-based medical adhesives, until its acquisition by Johnson & Johnson in 2005. He began his industry career at Medtronic, Inc., where he spent more than two decades. His executive assignments there included vice president of US marketing, and later in his career, the world wide responsibility for three different operating divisions as the Vice President and General Manager. Mr. Pelak is a graduate of Penn State University with a B.S. in Biology.
Dr. John P. Kostuik
Dr. John P. Kostuik is a Founder, Past Chairman, and the Chief Medical Officer of K2M. Dr. Kostuik was previously the Chief of Spine Surgery at The Johns Hopkins University School of Medicine. He also served as President of the Scoliosis Research Society and the North American Spine Society in which he was an original member/organizer. Dr. Kostuik is recognized as one of the world’s leading teachers and authorities on spine surgery. He has authored numerous papers ranging from the basic sciences of spinal pathologies to analysis and comparisons of advanced spinal technologies and patient treatments. Dr. Kostuik has been the keynote speaker at almost every major spine society in the world and has trained over 150 international spine fellows of which an estimated 145 are in active practice.
Mr. Eric Major
Eric Major is the President, CEO and Co-Founder of K2M, Inc., a fast growing global medical device company focused on developing innovative surgical solutions for the most complex spinal pathologies. Mr. Major was previously the President and CEO of American OsteoMedix, Inc., a minimally invasive spinal device company that was acquired by Interpore International in 2001. Mr. Major served as President of the Minimally Invasive Division of Interpore International until 2002.
Mr. Major has 15 years of experience in the spine industry. Prior to founding American OsteoMedix he served in several sales/marketing, strategic and product development capacities with various spinal companies including Acromed Spine (now a Johnson & Johnson company) and Synthes Spine, Inc. Mr. Major holds a B.S. degree from James Madison University.
Mr. Paul Queally
Paul Queally is Co-President of Welsh, Carson, Anderson & Stowe (WCAS) and a member of the Executive Committee and the Management Committee with a focus on investments in the healthcare industry. Prior to joining WCAS, Mr. Queally was a General Partner at The Sprout Group, Donaldson, Lufkin & Jenrette’s private equity group. Mr. Queally received a B.A. degree from the University of Richmond in 1986 and an M.B.A. from Columbia Business School in 1990.
Mr. Raymond Ranelli
Raymond Ranelli joined Welsh, Carson, Anderson & Stowe (WCAS) in 2009 as a Senior Operating Executive. At WCAS, Mr. Ranelli is responsible for working with portfolio companies on financial and accounting issues, as well as internal controls, and ensuring best practices on Audit Committees. He began his relationship with WCAS in 1983 while serving as a Transaction Services Partner from PricewaterhouseCoopers. He retired from PricewaterhouseCoopers in 2003 where he was a partner for over 21 years. Mr. Ranelli held several positions at PricewaterhouseCoopers, including Audit Partner, Transaction Services Partner, Managing Partner of the Washington D.C. Regional Offices and Vice Chairman and Global Leader of the Financial Advisory Services practice with operations in 20 countries. Mr. Ranelli has served on Audit Committees of several WCAS portfolio companies since 2003.
Mr. Ranelli has held leadership positions in several business and charitable organizations. He has received Lifetime Achievement Awards from both the National Leukemia Society and the National Kidney Foundation.
Mr. Sean Traynor
Sean Traynor is a member of the Management Committee at Welsh, Carson, Anderson & Stowe (WCAS) with a focus on investments in the healthcare industry. Prior to joining WCAS, he worked in the healthcare and insurance investment banking groups at BT Alex. Brown. Mr. Traynor spent three years with Coopers & Lybrand. He earned a bachelor’s degree from Villanova University in 1991 and an M.B.A. from the Wharton School of Business in 1996.
Mr. Brett Brodnax
Brett Brodnax serves as President and Chief Development Officer of United Surgical Partners International (USPI). Before joining USPI in 1999, he was an executive with the Baylor Health Care System in Dallas, where he gained extensive experience creating physician and hospital partnerships and developing surgical facilities. Mr. Brodnax holds a bachelor’s and master’s degree in Industrial Engineering from Texas A&M University and a master’s degree in Business Administration from the University of Texas at Dallas.
Mr. Carlos A. Ferrer
Carlos A. Ferrer is a founding member of Ferrer Freeman & Company, LLC (FFC). Prior to creating FFC, Mr. Ferrer spent seventeen years at Credit Suisse First Boston, where he started their Health Care Investment Banking Group. He has served on the Board of Directors of many FFC portfolio companies and currently participates as Director on the Boards of AgaMatrix, Inc., Ardent Health Services, LLC, GeneraMedix Pharmaceuticals Inc., Ancillary Advantage, Inc., and Preferred Care Partners Holding, Corp. and as a Trustee of the Cancer Research Institute. He graduated from Princeton University in 1976.